TSC22D3 and neoplasm: TSC22D3 is a glucocorticoid-inducible transcriptional regulator and also an immunosuppressive transcription factor, the activation of this gene will lead to immunosuppressive effect and the failure of the anti-tumor immunotherapy (45–47).